Pfizer Inc., the world’s largest drugmaker, is shrinking its operations to deliver on its profit forecast for 2012 — the first full year its $10 billion Lipitor cholesterol drug faces cheaper U.S. generics.
*For more on this story, read the full Reuters article.
